Jove
Visualize
Contact Us

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.4K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

542
The pathophysiology of pneumonia involves the following steps:
542

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of <i>gem</i>-Dimethyl-hydroxymethylpyridine Derivatives as Potent Non-nucleoside RSV Polymerase Inhibitors.

Journal of medicinal chemistry·2024
Same author

Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs.

mAbs·2018
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Sep 9, 2025

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.0K

Lamb Model of RSV Infection.

Sarhad Alnajjar1,2, Jack Gallup3, Mark Ackermann4

  • 1Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK. sarhad@lambcure.com.

Methods in Molecular Biology (Clifton, N.J.)
|August 29, 2025
PubMed
Summary
This summary is machine-generated.

The lamb model offers a valuable preclinical tool for studying respiratory syncytial virus (RSV) infections. This model aids in evaluating antiviral compounds and vaccines before human clinical trials.

Keywords:
Lamb model of RSV infectionRespiratory syncytial virus (RSV)

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.1K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.1K

Related Experiment Videos

Last Updated: Sep 9, 2025

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.0K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.1K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.1K

Area of Science:

  • Virology
  • Infectious Diseases
  • Preclinical Research

Background:

  • Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in vulnerable populations.
  • Existing animal models are used to test RSV therapeutics, but limitations exist.
  • The lamb model presents unique advantages for studying RSV.

Purpose of the Study:

  • To detail the protocol for utilizing the lamb model in RSV infection studies.
  • To highlight the suitability of the lamb model for preclinical evaluation of antiviral agents and vaccines.

Main Methods:

  • Infection of lambs with human RSV.
  • Detailed explanation of the experimental protocol.
  • Description of assays to assess infection severity.

Main Results:

  • The lamb model mimics human infant respiratory system characteristics.
  • Lambs are susceptible to human RSV, allowing for relevant infection studies.
  • The model facilitates evaluation of multiple therapeutic approaches and experimental designs.

Conclusions:

  • The lamb model is a robust preclinical model for RSV research.
  • It enables comprehensive assessment of antiviral compounds and vaccine efficacy.
  • This model supports the advancement of RSV therapeutics towards human clinical trials.